PERLETTI, GIANPAOLO
 Distribuzione geografica
Continente #
NA - Nord America 12.804
EU - Europa 8.129
AS - Asia 4.958
SA - Sud America 783
AF - Africa 243
OC - Oceania 144
Continente sconosciuto - Info sul continente non disponibili 14
Totale 27.075
Nazione #
US - Stati Uniti d'America 12.563
IT - Italia 4.097
SG - Singapore 1.477
UA - Ucraina 1.250
CN - Cina 663
SE - Svezia 660
TR - Turchia 652
BR - Brasile 639
VN - Vietnam 580
HK - Hong Kong 566
GB - Regno Unito 400
IE - Irlanda 384
DE - Germania 334
FI - Finlandia 309
IN - India 219
RU - Federazione Russa 197
CA - Canada 150
AU - Australia 124
FR - Francia 110
IQ - Iraq 98
PK - Pakistan 90
ID - Indonesia 85
IR - Iran 85
JP - Giappone 66
MX - Messico 66
ES - Italia 58
KR - Corea 56
PL - Polonia 55
AR - Argentina 51
TW - Taiwan 48
ZA - Sudafrica 48
EG - Egitto 47
NG - Nigeria 44
BE - Belgio 43
BD - Bangladesh 41
MY - Malesia 39
NL - Olanda 37
TH - Thailandia 33
PH - Filippine 29
GR - Grecia 26
CZ - Repubblica Ceca 22
EC - Ecuador 22
PE - Perù 22
AT - Austria 21
BG - Bulgaria 19
GH - Ghana 19
UG - Uganda 19
NP - Nepal 18
RS - Serbia 18
NZ - Nuova Zelanda 17
CO - Colombia 16
JO - Giordania 16
DZ - Algeria 15
MA - Marocco 14
CH - Svizzera 13
EU - Europa 13
IL - Israele 13
KE - Kenya 13
RO - Romania 12
SA - Arabia Saudita 12
VE - Venezuela 11
PT - Portogallo 10
QA - Qatar 10
YE - Yemen 10
LT - Lituania 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
SK - Slovacchia (Repubblica Slovacca) 8
TN - Tunisia 8
AL - Albania 7
CL - Cile 7
DK - Danimarca 7
HU - Ungheria 7
PY - Paraguay 6
CU - Cuba 5
PS - Palestinian Territory 5
UY - Uruguay 5
AZ - Azerbaigian 4
ET - Etiopia 4
HN - Honduras 4
SN - Senegal 4
BO - Bolivia 3
FJ - Figi 3
GT - Guatemala 3
KW - Kuwait 3
LB - Libano 3
LK - Sri Lanka 3
LU - Lussemburgo 3
MD - Moldavia 3
MM - Myanmar 3
SD - Sudan 3
SI - Slovenia 3
SV - El Salvador 3
AF - Afghanistan, Repubblica islamica di 2
BH - Bahrain 2
BW - Botswana 2
CR - Costa Rica 2
CY - Cipro 2
GE - Georgia 2
KZ - Kazakistan 2
Totale 27.051
Città #
Milan 2.818
Fairfield 1.592
Woodbridge 1.031
Ashburn 982
Jacksonville 953
Chandler 821
Singapore 816
Houston 795
Seattle 679
Wilmington 616
Cambridge 566
Hong Kong 524
Ann Arbor 493
Dublin 370
Princeton 368
Dearborn 343
Nyköping 337
Izmir 300
Dallas 298
Rome 231
Boardman 224
Beijing 213
Dong Ket 195
Como 167
Chicago 133
San Mateo 122
The Dalles 118
San Diego 116
Los Angeles 112
New York 102
Ho Chi Minh City 81
Ogden 76
London 69
Santa Clara 62
Hanoi 52
São Paulo 50
Tokyo 50
Montreal 40
Munich 39
Warsaw 37
Brisbane 36
Nanjing 35
Hefei 33
Kocaeli 33
Verona 33
Jakarta 32
Brooklyn 31
Kunming 31
Sydney 31
Toronto 31
Bangkok 30
Sulaymaniyah 29
Washington 29
San Francisco 27
Phoenix 25
Atlanta 24
Council Bluffs 24
Lahore 24
Pioltello 24
Rio de Janeiro 24
Guangzhou 22
Johannesburg 22
Portland 21
Rozzano 21
Baghdad 20
Brussels 20
Chennai 20
Denver 20
Nuremberg 20
Mexico City 19
Pune 19
Stockholm 19
Boston 18
Cairo 18
Helsinki 18
Orem 18
Brno 17
Kampala 17
Melbourne 17
Mumbai 17
Norwalk 17
Taipei 17
Adelaide 16
Amman 16
Kuala Lumpur 16
Moscow 16
City of Westminster 15
Lambeth 15
Sofia 15
Auburn Hills 14
Belgrade 14
Bengaluru 14
Brasília 14
Dhaka 14
Lagos 14
Madrid 14
Manchester 14
Accra 13
Ankara 13
Berlin 13
Totale 18.254
Nome #
Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer 798
Infectious complications of endourological treatment of kidney stones: A meta-analysis of randomized clinical trials 637
Drug-induced gynecomastia: A systematic review and meta-analysis of randomized clinical trials 567
Serenoa repens and its effects on male sexual function. A systematic review and meta-analysis of clinical trials 304
Effect of alpha-adrenoceptor antagonists on sexual function. A systematic review and meta-analysis 245
Prostatic calcifications are associated with a more severe symptom burden in men with type II chronic bacterial prostatitis 244
5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid. 233
The Integral Theory System Questionnaire: an anatomically directed questionnaire to determine pelvic floor dysfunctions in women 230
Analysis of chromosomal radiosensitivity of healthy BRCA2 mutation carriers and non-carriers in BRCA families with the G2 micronucleus assay 216
Aminoglycoside antibiotics for NIH category II chronic bacterial prostatitis: A single-cohort study with one-year follow-up 215
Serenoa repens and Pygeum Africanum in the treatment of BPH 213
ANALYSIS OF CALCIUM-DEPENDENT PROTEIN-KINASE-C ISOFORMS IN THE EARLY STAGES OF DIETHYLNITROSAMINE-INDUCED RAT HEPATOCARCINOGENESIS 212
Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex 208
Discrepancies between in silico and in vitro data in the functional analysis of a breast cancer-associated polymorphism in the XRCC6/Ku70 gene. 206
Eradication of Chlamydia trachomatis parallels symptom regression in chronic bacterial prostatitis patients treated with a fluoroquinolone-macrolide combination. 204
Combined effect of polymorphisms in Rad51 and Xrcc3 on breast cancer risk and chromosomal radiosensitivity 199
Are oxygen radicals responsible for the acute cardiotoxicity of doxorubicin? 199
Chronic bacterial prostatitis: enterococcal disease? 195
A new approach to the direct detection of free radicals in the intact myocardium. 194
National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndrome. 193
Effect of HIF-1 modulation on the response of two- and three-dimensional cultures of human colon cancer cells to 5-fluorouracil 190
Polymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivity. 189
Natural history of human papillomavirus infection in non-vaccinated young males: low clearance probability in high-risk genotypes 189
Characterization of the c.190T>C missense mutation in BRCA1 codon 64 (Cys64Arg). 187
Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients 187
Anti-infective treatment of bacterial urinary tract infections. 186
Risk of urinary stone formation associated to proton pump inhibitors: a systematic review and metanalysis 184
Comparative analysis of molecular strategies attenuating positional effects in lentiviral vectors carrying multiple genes 183
Fluoroquinolone-macrolide combination therapy for chronic bacterial prostatitis: retrospective analysis of pathogen eradication rates, inflammatory findings and sexual dysfunction. 183
Azithromycin: mechanisms of action and their relevance for clinical applications. 179
Prevalence of erectile and ejaculatory dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome 178
Computer-assisted quantitative assessment of prostatic calcifications in patients with chronic prostatitis 178
A severely symptomatic case of anaerobic chronic bacterial prostatitis successfully resolved with moxifloxacin therapy. 177
α-blockers and antibiotics, alone or in combination, improve symptoms in men with chronic prostatitis/chronic pelvic pain syndrome. 177
Activity of Serenoa repens, lycopene and selenium on prostatic disease: evidences and hypotheses. 176
Semen analysis in chronic bacterial prostatitis: diagnostic and therapeutic implications. 176
Increased chromosomal radiosensitivity in asymptomatic carriers of a heterozygous BRCA1 mutation 175
Macrolides for the treatment of chronic bacterial prostatitis: an effective application of their unique pharmacokinetic and pharmacodynamic profile (Review). 173
Antimicrobials in urogenital infections. 172
p21(Waf1/Cip1) and p53 are downstream effectors of protein kinase C delta in tumor suppression and differentiation in human colon cancer cells 170
National institute of health chronic prostatitis symptom index (CPSI) symptom evaluation in patients with chronic prostatitis / chronic pelvic pain syndrome - A multinational study in 1,563 patients 170
FRAIL scale as a predictor of complications and mortality in older patients undergoing reconstructive surgery for non-melanoma skin cancer 170
Antimicrobial therapy for chronic bacterial prostatitis. 169
Use of the UPOINT chronic prostatitis/chronic pelvic pain syndrome classification in European patient cohorts: sexual function domain improves correlations. 169
INTERACTION OF CU(II) AND CU(II)-ANTHRACYCLINE COMPLEXES WITH PROTEIN-KINASE-C - SPECTROMAGNETIC ASSESSMENT OF THE INHIBITORY EFFECT 168
Efficacy and safety of second-line agents for treatment of metastatic castration-resistant prostate cancer progressing after docetaxel. A systematic review and meta-analysis 168
Structure and function of the extraembryonic membrane persisting around the larvae of the parasitoid Toxoneuron nigriceps. 167
A polymorphism in the promoter region of Ku70/XRCC6, associated with breast cancer risk and oestrogen exposure. 167
A switch therapy protocol with intravenous azithromycin and ciprofloxacin combination for severe, relapsing chronic bacterial prostatitis: a prospective non-comparative pilot study. 166
Finafloxacin for the treatment of urinary tract infections 166
Efficacy of repeated cycles of combination therapy for the eradication of infecting organisms in chronic bacterial prostatitis 165
Emerging second-line therapies for advanced, androgen deprivation-refractory prostate cancer in the post-docetaxel setting 163
Inflammatory cues acting on the adult intestinal stem cells and the early onset of cancer (Review) 162
Prevention and modulation of aminoglycoside ototoxicity (Review) 161
DIFFERENTIAL PHORBOL ESTER GROWTH MODULATION AND PROTEIN-KINASE-C ISOENZYME EXPRESSION IN RAT HEPATOMA-CELLS VS NON NEOPLASTIC RAT HEPATOCYTES 160
Reply to: Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer 160
Multiparametric magnetic resonance imaging characteristics of normal, benign and malignant conditions in the prostate 160
PROTECTIVE EFFECTS OF SPIN-TRAPPING AGENTS ON ADRIAMYCIN-INDUCED CARDIOTOXICITY IN ISOLATED RAT ATRIA 159
Growth factors and chemokines: a comparative functional approach between invertebrates and vertebrates. 155
Polymorphisms in nonhomologous end joining genes associated with breast cancer risk and chromosomal radiosensitivity. 155
Leech responses to tissue transplantation 154
Risk factors analysis in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) from Finland, Germany, Italy and Switzerland: Results of a multinational observational study 154
Emerging drugs for bacterial urinary tract infections. 152
Phosphatidylethanolamine N-methyltransferase 2 and CTP-phosphocholine cytidylyltransferase expressions are related with protein kinase C isozymes in developmental liver growth 151
PROTEIN-KINASE-C ISOZYME PATTERN IN LIVER HYPERPLASIA 151
PROTEIN-KINASE-C ISOZYMES DURING LIVER-REGENERATION 151
PARTIAL-PURIFICATION OF PROTEIN-KINASE-C ISOENZYMES FROM RAT-LIVER 151
Chlamydia trachomatis infection is related to premature ejaculation in chronic prostatitis patients: Results from a cross-sectional study 151
THE INHIBITORY EFFECT OF CU(II) ON PROTEIN-KINASE-C IS ENHANCED BY ANTHRACYCLINES - AN ESR STUDY 150
A switch therapy protocol with intravenous azithromycin and ciprofloxacin combination for severe, relapsing chronic bacterial prostatitis: a prospective non-comparative pilot study. 150
Topographic and quantitative relationship between prostate inflammation, proliferative inflammatory atrophy and low-grade prostate intraepithelial neoplasia: A biopsy study in chronic prostatitis patients 149
Collagen organization in leech wound healing. 148
Re: Samplaski et al.: Inclusion of erectile domain to UPOINT phenotype does not improve correlation with symptom severity in men with chronic prostatitis/chronic pelvic pain syndrome. (Urology 2011;78:653-658). 148
Eradication of unusual pathogens by combination pharmacological therapy is paralleled by improvement of signs and symptoms of chronic prostatitis syndrome 145
Reduction of PSA values by combination pharmacological therapy in patients with chronic prostatitis: implications for prostate cancer detection. 144
Hypoxia as a risk factor for doxorubicin-induced cardiotoxicity: a NMR evaluation. 144
Resistance of uropathogens to antibacterial agents: Emerging threats, trends and treatments 144
Comparative analysis of immune responses and cytokine profiles elicited in rabbits by the combined use of recombinant fowlpox viruses, plasmids and virus-like particles in prime-boost vaccination protocols against SHIV 143
ANALYSIS OF CALCIUM-DEPENDENT PROTEIN-KINASE-C ISOENZYMES IN INTRINSICALLY RESISTANT CLONED LINES OF LOVO CELLS - REVERSAL OF RESISTANCE BY KINASE INHIBITOR 1-(5-ISOQINOLINYLSULFONYL) 2-METHYLPIPERAZINE 142
THE ACTIVITY OF A BETA-SUBTYPE OF PROTEIN-KINASE-C PURIFIED FROM NUCLEI OF HUMAN NEUTROPHILS IS ENHANCED BY TREATMENT WITH PHORBOL 12-MYRISTATE 13-ACETATE 142
Resistance of human leukemic cell lines to 1-beta-D-arabinofuranosylcytosine: characterization of an experimental model 141
Distinctive cellular roles for novel protein kinase C isoenzymes 141
Multidisciplinary approach to prostatitis 139
VEGF stimulates angiogenesis in Hirudo medicinalis. 138
Effect of doxorubicin on calcium receptors of myocardial cells. 138
Herbal medicines for urinary stone treatment. A systematic review 138
Chlamydia trachomatis versus common uropathogens as a cause of chronic bacterial prostatitis: Is there any difference? Results of a prospective parallel-cohort study 138
Early suppression of immune response in Heliothis virescens larvae by the endophagous parasitoid Toxoneuron nigriceps 138
The association between prostatitis and prostate cancer. Systematic review and meta-analysis 137
Current knowledge of the potential links between inflammation and prostate cancer 137
Wound repair in Hirudo medicinalis: phases and response modulation 136
Leeches: Immune response, angiogenesis and biomedical applications 136
Antimicrobials in urogenital infections. 135
The radiosensitizing effect of Ku70/80 knockdown in MCF10A cells irradiated with X-rays and p(66)+Be(40) neutrons. 134
Levofloxacin for NIH Category II Chronic Bacterial Prostatitis: A Real-Life Study 133
Hirudo medicinalis: un nuovo modello sperimentale per lo studio dell’angiogenesi 132
Collagen reorganization in leech wound healing. 132
Hematopoietic cell formation in leech wound healing. 131
Antitumor activity of Endostatin against carcinogen-induced rat primary mammary tumors 130
Lentivirus-mediated RNA interference of Ku70 to enhance radiosensitivity of human mammary epithelial cells. 130
Totale 18.279
Categoria #
all - tutte 107.655
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.655


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.000 0 0 0 0 0 344 83 223 398 223 268 461
2021/20221.970 190 191 128 173 31 99 82 152 258 240 154 272
2022/20232.265 262 122 235 199 170 488 3 284 285 79 75 63
2023/20244.839 675 731 765 812 905 256 60 109 148 118 117 143
2024/20254.058 136 145 605 134 184 221 176 303 417 422 404 911
2025/20263.648 608 494 440 1.054 749 303 0 0 0 0 0 0
Totale 27.300